SCOTT LIANG: Open Payments
NPI 1639124514 · ARCADIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,252 in 45 payments from 15 companies in 2025. Trend: 2023 $1,510 · 2024 $1,101 · 2025 $1,252
Food & beverage: $1,252
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $280 |
| Amgen Inc. | 7 | $249 |
| AstraZeneca Pharmaceuticals LP | 9 | $220 |
| GlaxoSmithKline, LLC. | 3 | $86 |
| Corcept Therapeutics | 2 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $81 |
| ABBVIE INC. | 2 | $45 |
| PFIZER INC. | 2 | $38 |
| Radius Health, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $28 |
Products named: Ozempic, KRYSTEXXA, OTEZLA, BREZTRI, TRELEGY ELLIPTA, Korlym, JARDIANCE, AIRSUPRA.
Industry payments across CA — which companies pay providers there.
